Improving Behavioral Health for Caregivers and Children After Pediatric Injury
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Feb 25, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping children and their caregivers cope with the emotional and behavioral effects of pediatric traumatic injuries (PTI). Each year, over 125,000 children in the U.S. are hospitalized due to injuries, and both the children and their families often face challenges like PTSD, depression, and difficulties in daily life and school. The study will test a new program called CAARE (Caregivers' Aid to Accelerate Recovery after pediatric Emergencies) that offers support to families after these injuries. A total of 348 families will be involved, with half receiving CAARE and the other half receiving standard care.
To participate in this trial, caregivers must be at least 18 years old and have a child under 12 who has been hospitalized for an injury. The child must also show signs of distress. Unfortunately, caregivers who do not speak English as their first language or who have certain cognitive challenges will not be eligible. If you join the trial, you can expect to receive either the new support program or standard care during a time when your family is navigating the aftermath of an injury. This research aims to create better support systems for families facing these difficult situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Caregivers (≥18 years old) of children hospitalized with pediatric injury
- • Children hospitalized with pediatric injury \<12 years old
- • Screen positive on the ASC-Kids (aged 8-11 years) or PDI Caregiver measure of acute distress.
- Exclusion Criteria:
- • A caregiver whose primary language is not English
- • A cognitive challenge (caregiver or child) that would impair ability to consent
- • Presence of a self-afflicted injury
- • Presence of injuries resulting from caregiver abuse or neglect (these patients will follow an alternative treatment path).
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Ann Arbor, Michigan, United States
Houston, Texas, United States
Lexington, Kentucky, United States
Patients applied
Trial Officials
Leigh Ridings, Ph.D.
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported